At Santen, our single focus in ophthalmology enables
research of novel therapies in uveitis, glaucoma, and
dry eye/corneal disorders—therapies determined to
challenge eye disease, one patient at a time.
Inspiring ophthalmic medicines
Live: 10"x13" Carling Communications Issue Date: 4/26-29/2014
T
Our motivation. His uveitis.
To see our innovative science
in action, scan this code with
your mobile device or visit
www.santeninc.com.
Image is designed to represent uveitis visual impairment and is not intended
to be medically accurate. For illustrative purposes only.
© 2012 Santen Pharmaceutical Co., Ltd. All rights reserved. SAN-270.00 07/12
